https://www.selleckchem.com/pr....oducts/cobimetinib-g
Racial and ethnic disparities are a barrier in delivery of healthcare across the USA. Care for minority patients tends to be clustered into a small number of providers at minority hospitals, which has been associated with worse clinical outcomes in several conditions. However, the outcomes of treatment in patients with end-stage liver disease (ESLD) at predominately minority hospitals are unknown. We investigated the burden of the problem. We utilized the nationwide in-patient sample (NIS) to conduct a retrospective
Like
Comment
Share
